Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: A metanalysis of genotype-phenotype correlations

American Journal of Human Genetics

Volumn 61, Issue 6, 1997, Pages 1309-1317

  Kayaalp, Emre ^a   Treacy, Eileen ^a,b   Waters, Paula J ^a,b   Byck, Susan ^a   Nowacki, Piotr ^a,b   Scriver, Charles R ^a,b,c  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLALANINE 4 MONOOXYGENASE;

ARTICLE; GENE LOCUS; GENE MUTATION; GENOTYPE; HUMAN; HYPERPHENYLALANINEMIA; META ANALYSIS; PHENOTYPE; PHENYLKETONURIA; PRIORITY JOURNAL;

EID: 0031472356     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/301638     Document Type: Article

References (67)

1. Ad Hoc Committee (1996) Update on nomenclature for human gene mutations. Hum Mutat 8:197-202
2. Apold J, Eiken HG, Froysa KE, Moyzfeldt K (1993) Estimation of the severity of individual hyperphenylalaninemia mutations from untreated serum phenylalanine concentration. Dev Brain Dysfunct 6:109-113
3. Armstrong MD, Tyler FH (1955) Studies on phenylketonuria. I. Restriction phenylalanine intake in phenylketonuria. J Clin Invest 34:565-580
4. Bénit P, Rey F, Melle D, Munich A, Key J (1994) Five novel missense mutations of the phenylalanine hydroxylase gene in phenylketonuria. Hum Mutat 4:229-231
5. Beutler E, McKusick VA, Motolsky AG, Scriver CR, Hutchinson F (1996) Mutation nomenclature: nicknames, systematic names, and unique identifiers. Hum Mutat 8:203-206
6. Bickel H, Gerrard J, Hickmans EM (1954) Influence of phenylalanine intake on the chemistry and behaviour of a phenylketonuric child. Acta Paediatr 43:64-77
7. Burgard P, Rupp A, Konecki DS, Trefz FK, Schmidt H, Lichter-Konecki UL (1996) Phenylalanine hydroxylase genotypes, predicted residual enzyme activity and phenotypic parameters of diagnosis and treatment of phenylketonuria. Eur J Pediatr 155:S11-S15
8. Desviat LR, Pérez B, De Lucca M, Cornejo V, Schmidt B, Ugarte M (1995) Evidence in Latin America of recurrence of V388M, a phenylketonuria mutation with high in vitro residual activity. Am J Hum Genet 57:337-342
9. Dianzani I, Giannattasio G, de Sanctis L, Alliaudi C, Lattanzio P, Dionisi Vici CD, Burlina A, et al (1995) Characterization of phenylketonuria alleles in the Italian population. Eur J Hum Genet 3:294-302
10. Dianzani I, Knappskog PM (1995) Novel missense mutation in the phenylalanine hydroxylase gene leading to complete loss of enzymatic activity. Hum Mutat 6:247-249
11. Dickson PW, Jennings IG, Cotton RGH (1994) Delineation of the catalytic core of phenylalanine hydroxylase and identification of glutamate 286 as a critical residue for pterin function. J Biol Chem 269:20369-20375
12. DiLella AG, Kwok SCM, Ledley FD, Marvit J, Woo SLC (1986) Molecular structure and polymorphic map of human phenylalanine hydroxylase gene. Biochemistry 25:743-749
13. Di Silvestre D, Koch R, Groffen J (1991) Different clinical manifestations of hyperphenylalaninemia in three siblings with identical phenylalanine hydroxylase genes. Am J Hum Genet 48:1014-1016
14. Dworniczak B, Kalaydjieva L, Aulehla-Scholz C, Ullrich K, Kremensky I, Radeva B, Horst J (1991) Recurrent nonsense mutation in exon 7 of the phenylalanine hydroxylase gene. Hum Genet 87:731-733
15. Eiken HG, Knappskog PM, Apold J, Fiatmark T (1996a) PKU mutation G46S is associated with increased aggregation and degradation of the phenylalanine hydroxylase enzyme. Hum Mutat 7:228-238
16. Eiken HG, Knappskog PM, Motzfeldt K, Boman H, Apold J (1996b) Phenylketonuria genotypes correlated to metabolic phenotype groups in Norway. Eur J Pediatr 155:554-560
17. Gibbs BS, Wojchowski D, Benkovic SJ (1993) Expression of rat liver phenylalanine hydroxylase in insect cells and site-directed mutagenesis of putative non-heme iron-binding sites. J Biol Chem 268:8046-8052
18. Guldberg P, Henriksen FF, Thony B, Blau N, Guttler F (1994a) Molecular heterogeneity of nonphenylketonuria hyperphenylalaninemia in 25 Danish patients. Genomics 21:453-455
19. Guldberg P, Levy HL, Henriksen KF, Guttler F (1996) Three prevalent mutations in a patient with phenylalanine hydroxylase deficiency: implications for diagnosis and genetic counselling. J Med Genet 33:161-164
20. Guldberg P, Levy HL, Koch R, Berlin CMJ, Francois B, Henriksen KF, Guttler F (1994b) Mutation analysis in families with discordant phenotypes of phenylalanine hydroxylase deficiency: inheritance and expression of the hyperphenylalaninaemias. J Inherit Metab Dis 17:645-651
21. Guldberg P, Mikkelsen I, Henriksen KF, Lou HC, Güttler F (1995) In vivo assessment of mutations in the phenylalanine hydroxylase gene by phenylalanine loading: characterization of seven common mutations. Eur J Pediatr 154:551-556
22. Güttler F, Guldberg P, Henriksen KF (1993) Mutation genotype of mentally retarded patients with phenylketonuria. Dev Brain Dysfunct 6:92-96
23. Güttler F, Ledley FD, Lidsky AS, DiLella AG, Sullivan SE, Woo SLC (1987) Correlation between polymorphic DNA haplotypes at the phenylalanine hydroxylase locus and clinical phenotypes of phenylketonuria. J Pediatr 110:68-71
24. John SWM, Scriver CR, Laframboise R, Rozen R (1992) In vitro and in vivo correlations for I65T and M1V mutations at the phenylalanine hydroxylase locus. Hum Mutat 1: 147-153
25. Kacser H, Burns JA (1981) The molecular basis of dominance. Genetics 97:639-666
26. Kalaydjieva L, Dworniczak B, Kremensky I, Koprivarova K, Radeva B, Milusheva R, Aulehla-Scholz C, et al (1992) Heterogeneity of mutations in Bulgarian phenylketonuria haplotype 1 and 4 alleles. Clin Genet 41:123-128
27. Kayaalp E, Carter K, Waters PJ, Byck S, Treacy E, Scriver CR, PAH Mutation Analysis Consortium (1996) Mutant PAH genotypes and associated metabolic phenotypes: a meta-analysis. Am J Hum Genet Suppl 59:A201
28. Kleiman S, Vanagaite L, Bernstein L, Schwartz G, Brand N, Elitzur A, Woo SLC, et al (1993) Phenylketonuria: variable phenotypic outcomes of the R261Q mutation and maternal PKU in the offspring of a healthy homozygote. J Med Genet 30:284-288
29. Konecki DS, Wang Y, Trefz FK, Lichter-Konecki U, Woo SLC (1992) Structural characterization of the 5′ region of the human phenylalanine hydroxylase gene. Biochemistry 31: 8363-8368
30. Kowlessur D, Yang X, Kaufman S (1995) Further studies of the role of Ser-16 in the regulation of the activity of phenylalanine hydroxylase. Proc Nad Acad Sci USA 92: 4743-4747
31. Kunert E, Wolf C, Güttler F, Tyfield LA, Rutland P, Bührdel P, Theile H (1993) Correlation of phenotype and genotype in phenylketonuria patients of eastern FGR homozygous for the R408W and R261Q point mutations of the phenylalanine hydroxylase locus. Dev Brain Dysfunct 6:114-119
32. Kwok SCM, Ledley FD, DiLella AG, Robson KJH, Woo SLC (1985) Nucleotide sequence of a full-length complementary DNA clone and amino acid sequence of human phenylalanine hydroxylase. Biochemistry 24:556-561
33. Langenbeck U, Lukas HD, Mench-Hoinowski A, Stenzig KP, Lane JD (1988) Correlative study of mental and biochemical phenotypes in never treated patients with classic phenylketonuria. Brain Dysfunct 1:103-110
34. Ledley FD, Levy HL, Woo SLC (1986) Molecular analysis of the inheritance of phenylketonuria and mild hyperphenylalaninemia in families with both disorders. N Engl J Med 314: 1276-1280
35. Lidsky AS, Ledley FD, DiLella AG, Kwok SCM, Daiger SP, Robson KJH, Woo SLC (1985) Extensive restriction site polymorphism at the human phenylalanine hydroxylase locus and application in prenatal diagnosis of phenylketonuria. Am J Hum Genet 37:619-634
36. Lyonnet S, Caillaud C, Rey F, Berthelon M, Frézal J, Rey J, Munnich A (1989) Molecular genetics of phenylketonuria in Mediterranean countries: a mutation associated with partial phenylalanine hydroxylase deficiency. Am J Hum Genet 44:511-517
37. Martinez-Pardo M, Colmenares AR, Garcia MJ, Pérez B, Desviat LR, Ugarte M (1994) Phenotype distribution in the Spanish phenylketonuria population and related genotypes. J Inherit Metab Dis 17:366-368
38. Mayr E (1982) The growth of biological thought: diversity, evolution and inheritance. Belknap Press of Harvard University Press, Cambridge, MA
39. Nowacki P, Byck S, Prevost L, Scriver CR (1997) The PAH Mutation Analysis Consortium database: update 1996. Nucleic Acids Res 25:139-142
40. Okano Y, Eisensmith RC, Guttler F, Lighter-Konecki U, Konecki DS, Trefz FK, Dasovich M, et al (1991a) Molecular basis of phenotypic heterogeneity in phenylketonuria. N Engl J Med 324:1232-1238
41. Okano Y, Eisensmith RC, Longhi R, Riva E, Giovannini M, Cerone R, Romano C, et al (1991b) Phenylketonuria missense mutations in the Mediterranean. Genomics 9:96-103
42. Okano Y, Wang T, Eisensmith RC, Steinmann B, Gitzelmann R, Woo SLC (1990) Missense mutations associated with RFLP haplotypes 1 and 4 of the human phenylalanine hydroxylase gene. Am J Hum Genet 46:18-25
43. Penrose LS (1946) Phenylketonuria: a problem in eugenics. Lancet 1:949-953
44. Pérez B, Desviat LR, Garcia MJ, Ugarte M (1994) Different phenotypic manifestations associated with identical phenylketonuria genotypes in the Spanish families. J Inherit Metab Dis 17:377-378
45. Pérez B, Lourdes R, Ugarte M (1995) Expression analysis of mutation P244L, which causes mild hyperphenylalaninemia. Hum Mutat 5:188-190
46. Quinsey NS, Lenaghan CM, Dickson PW (1997) Identification of Gln313 and Pro327 as residues critical for substrate inhibition in tyrosine hydroxylase. J Neurochem 66:908-914
47. Ramus SJ, Forrest SM, Pitt DB, Saleeba JA, Cotton RGH (1993) Comparison of genotype and intellectual phenotype in untreated PKU patients. J Med Genet 30:401-405
48. Romano V, Guldberg P, Guttler F, Meli C, Mollica F, Pavone L, Giovannini M, et al (1996) PAH deficiency in Italy: correlations of genotype to phenotype in the Sicilian population. J Inherit Metab Dis 19:15-24
49. Salter M, Knowles RG, Pogson CI (1986) Quantification of the importance of individual steps in the control of aromatic amino acid metabolism. Biochem J 234:635-647
50. Scriver CR (1991) Phenylketonuria - genotypes and phenotypes. N Engl J Med 324:1280-1281
51. Scriver CR, Gregory DM, Sovetts D, Tissenbaum G (1985) Normal plasma free amino acid values in adults: the influence of some common physiological variables. Metabolism 34:868-873
52. Scriver CR, Kaufman S, Eisensmith E, Woo SLC (1995) The hyperphenylalaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 7th ed. McGraw Hill, New York, pp 1015-1075
53. Scriver CR, Rosenberg LE (1973) Amino acid metabolism and its disorders. WB Saunders, Philadelphia
54. Svensson E, Eisensmith RC, Dworniczak B, Von Dobeln U, Hagenfeldt L, Horst J, Woo SLC (1992) Two missense mutations causing mild hyperphenylalaninemia associated with DNA haplotype 12. Hum Mutat 1:129-137
55. Svensson E, von Dobeln U, Eisensmith RC, Hagenfeldt L, Woo SLC (1993) Relation between genotype and phenotype in Swedish phenylketonuria and hyperphenylalaninemia patients. Eur J Pediatr 152:132-139
56. Treacy EP, Delente JJ, Elkas G, Carter K, Lambert M, Waters PJ, Scriver CR (1997) Analysis of phenylalanine hydroxylase genotypes and hyperphenylalaninemia phenotypes using L-[U-13C] phenylalanine oxidation rates in vivo: a pilot study. Pediatr Res 42:430-435
57. Treacy E, Pitt JJ, Seller J, Thompson GN, Ramus S, Cotton RGH (1996) In vivo disposal of phenylalanine in phenylketonuria: a study of two siblings. J Inherit Metab Dis 19: 595-602
58. Trefz FK, Burgard P, König T, Goebel-Schreiner B, Lichter-Konecki U, Konecki D, Schmidt E, et al (1993) Genotype-phenotype correlations in phenylketonuria. Clin Chim Acta 217:15-21
59. Tyfield LA, Zschocke J, Stephenson A, Cockburn F, Harvie A, Bidwell HJL, Wood NAP, et al (1995) Discordant phenylketonuria phenotypes in one family: the relationship between genotypes and clinical outcome is a function of multiple effects. J Med Genet 32:867-870
60. Waters J, Parniak MA, Nowacki P, Scriver CR (1998) In vitro expression analysis of mutations in human and rat phenylalanine hydroxylase: exploring molecular causes of hyperphenylalaninemia. Hum Mutat 11:4-17
61. Weinstein M, Eisensmith RC, Abadie V, Avigad S, Lyonnet S, Schwartz G, Munnich A, et al (1993) A missense mutation S349P, completely inactivates phenylalanine hydroxylase in North African Jews with phenylketonuria. Hum Genet 90: 645-649
62. Weiss KM (1996) Is there a paradigm shift in genetics? lessons from the study of human diseases. Mol Phylogenet Evol 5: 259-265
63. Woo SLC, Lidsky AS, Güttler F, Chandra T, Robson KJH (1983) Cloned human phenylalanine hydroxylase gene allows prenatal diagnosis and carrier detection of classical phenylketonuria. Nature 306:151-155
64. Woolf LI, Griffiths R, Moncrieff A (1955) Treatment of phenylketonuria with a diet low in phenylalanine. Br Med J 1: 57-64
65. Zschocke J, Graham CA, Stewart FJ, Carson DJ, Nevin NC (1994) Non phenylketonuria hyperphenylalaninemia in Northern Ireland: frequent mutation allows screening and early diagnosis. Hum Mutat 4:114-118
66. Zygulska AM, Eigel A, Pietrzyk JJ, Horst J (1994) Phenylketonuria in southern Poland: a new splice mutation in intron 9 at the PAH locus. Hum Mutat 4:297-299
67. Zygulska M, Eigel A, Dworniczak B, Sutkowska A, Pietrzyk JJ, Horst J (1991) Phenylketonuria in Poland: 66% of PKU alleles are caused by three mutations. Hum Genet 88:91-94